BMS and Otsuka Extend Abilify Partnership

By Taskin Ahmed

Pharma Deals Review: Vol 2009 Issue 4 (Table of Contents)

Published: 7 Apr-2009

DOI: 10.3833/pdr.v2009.i4.1088     ISSN: 1756-7874

Section: Licensing



Bristol-Myers Squibb is extending its partnership with Japan’s Otsuka Pharmaceuticals until 2015 on the US sales of their blockbuster psychiatric drug, Abilify® (aripiprazole)...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details